A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Chemistry and Biology

• Publication date

  2009-09-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.chembiol.2009.08.013PMID 19778722PMCID PMC3341621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthetic α -Helix Mimetics as Agonists and Antagonists of IAPP Amyloid Formation **

  2011cited by this paper
• Synthetic alpha-helix mimetics as agonists and antagonists of islet amyloid polypeptide aggregation.

  2010cited by this paper
• Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions.

  2009cited by this paper
• The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes.

  2009cited by this paper
• Interaction of membrane‐bound islet amyloid polypeptide with soluble and crystalline insulin

  2008cited by this paper
• alpha-Helix mimetics as inhibitors of protein-protein interactions.

  2008cited by this paper
• Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation.

  2008cited by this paper
• Chemical and biological approaches synergize to ameliorate protein-folding diseases.

  2008cited by this paper
• Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease.

  2008cited by this paper
• Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide.

  2008cited by this paper
• Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis.

  2008cited by this paper
• Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules.

  2008cited by this paper
• Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs

  2008cited by this paper
• Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide.

  2008cited by this paper
• Adapting Proteostasis for Disease Intervention

  2008cited by this paper
• Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid‐β peptide

  2008cited by this paper
• Amyloid-beta aggregation.

  2007cited by this paper
• Protein aggregation processes: In search of the mechanism

  2007cited by this paper
• Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR.

  2007cited by this paper
• Direct detection of transient α‐helical states in islet amyloid polypeptide

  2007cited by this paper
• Small molecule inhibitors of Abeta assembly

  2007influential reference
• Direct detection of transient alpha-helical states in islet amyloid polypeptide.

  2007cited by this paper
• Fiber-dependent amyloid formation as catalysis of an existing reaction pathway

  2007cited by this paper
• A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor.

  2007cited by this paper
• Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide.

  2006cited by this paper
• Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism

  2006influential reference
• Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis

  2006cited by this paper
• β-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes

  2006cited by this paper
• Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?

  2006cited by this paper
• Molecular structure of amyloid fibrils: insights from solid-state NMR

  2006cited by this paper
• Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.

  2006cited by this paper
• Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes.

  2006cited by this paper
• The mechanism of insulin action on islet amyloid polypeptide fiber formation.

  2004cited by this paper
• Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

  2004cited by this paper
• Molecular mechanism of Peptide-induced pores in membranes.

  2004cited by this paper
• Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.

  2004cited by this paper
• Type 2 diabetes mellitus is becoming the most common type of diabetes in school children

  2004cited by this paper
• Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.

  2004cited by this paper
• Phospholipid catalysis of diabetic amyloid assembly.

  2004cited by this paper
• Scrambled Prion Domains Form Prions and Amyloid

  2004cited by this paper
• Amylin receptors: molecular composition and pharmacology.

  2004cited by this paper
• Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases*

  2004cited by this paper
• Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions.

  2004cited by this paper
• Islet amyloid polypeptide and type 2 diabetes.

  2003cited by this paper
• A Broken α-Helix in Folded α-Synuclein*

  2003cited by this paper
• Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss

  2003cited by this paper
• Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.

  2003cited by this paper
• Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis.

  2002cited by this paper
• A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants

  2002cited by this paper
• Conformational properties of alpha-synuclein in its free and lipid-associated states.

  2001cited by this paper
• Characterization of cholyl-leu-val-phe-phe-ala-OH as an inhibitor of amyloid beta-peptide polymerization

  2001cited by this paper
• beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.

  2001cited by this paper
• Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion.

  2000cited by this paper
• Islet amyloid and type 2 diabetes mellitus.

  2000cited by this paper
• Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

  1999cited by this paper
• Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.

  1997cited by this paper
• The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR.

  1996cited by this paper
• Processing of pro‐islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2

  1996cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease.

  1994cited by this paper

• Modulating human IAPP aggregation in type 2 diabetes: inhibitors, mechanisms, and translational challenges.

  2026cites this paper
• Amylin and the amylin receptors in migraine: Is there another pathway to target?

  2025cites this paper
• Inhibition of Human Amylin Aggregation: In Silico and In Vitro Studies

  2025cites this paper
• Unnatural foldamers as inhibitors of Aβ aggregation via stabilizing the Aβ helix

  2025cites this paper
• A Polyproline Type II Peptidomimetic Disrupts a Grb2 SH3C Domain Protein–Protein Interaction Implicated in Breast Cancer

  2025cites this paper
• Prion protein-derived cell-penetrating peptide inhibits type II diabetes-associated islet amyloid polypeptide aggregation and cytotoxicity

  2025cites this paper
• Exploring Tryptophan-based Short Peptides: Promising Candidate for Anticancer and Antimicrobial Therapies.

  2024cites this paper
• DNA nanostructures prevent the formation of and convert toxic amyloid proteospecies into cytocompatible and biodegradable spherical complexes

  2024cites this paper
• Protein mimetic 2D FAST rescues alpha synuclein aggregation mediated early and post disease Parkinson’s phenotypes

  2024cites this paper
• Efficient optical plasmonic tweezer-controlled single-molecule SERS characterization of pH-dependent amylin species in aqueous milieus

  2023cites this paper
• "Common-Precursor" Protein Mimetic Approach to Rescue Aβ Aggregation-Mediated Alzheimer's Phenotypes.

  2023cites this paper
• Rationally designed helical peptidomimetics disrupt α-synuclein fibrillation.

  2022cites this paper
• Inhibition of Amyloid Protein Aggregation Using Selected Peptidomimetics

  2022cites this paper
• Regulation of oxaliplatin and carboplatin on the assembly behavior and cytotoxicity of human islet amyloid polypeptide.

  2022cites this paper
• A 2D Fragment-Assisted Protein Mimetic Approach to Rescue α-Synuclein Aggregation Mediated Early and Post-Disease Parkinson’s Phenotypes

  2022cites this paper
• Exploration of Isoquinoline Alkaloids as Potential Inhibitors against Human Islet Amyloid Polypeptide.

  2022cites this paper
• The crystal structure of N-cyclohexyl-3-hydroxy-4-methoxybenzamide, C14H19NO3

  2022cites this paper
• Small Molecule Inhibitors for Amyloid Aggregation

  2021cites this paper
• Islet amyloid toxicity: From genesis to counteracting mechanisms

  2021cites this paper
• Natural and Synthetic Oligoarylamides: Privileged Structures for Medical Applications

  2021cites this paper
• Synthesis and Evaluation of Arylamides with Hydrophobic Side Chains for Insulin Aggregation Inhibition.

  2021cites this paper
• Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators.

  2020cites this paper
• α-Helix-Mimetic Foldamers for Targeting HIV-1 TAR RNA.

  2019cites this paper
• Influence of methionine–ruthenium complex on the fibril formation of human islet amyloid polypeptide

  2019cites this paper
• Computational and Experimental Approaches to Design Inhibitors of Amylin Aggregation.

  2019cites this paper
• Synthesis and identification of novel pyridazinylpyrazolone based diazo compounds as inhibitors of human islet amyloid polypeptide aggregation.

  2019cites this paper
• Targeting the Intrinsically Disordered Proteome Using Small-Molecule Ligands.

  2018cites this paper
• Membrane-mediated amyloid deposition of human islet amyloid polypeptide

  2018cites this paper
• Interaction between amyloidogenic proteins and biomembranes in protein misfolding diseases: Mechanisms, contributors, and therapy.

  2018cites this paper
• Regulation of heteronuclear Pt-Ru complexes on the fibril formation and cytotoxicity of human islet amyloid polypeptide.

  2018cites this paper
• IAPP in type II diabetes: Basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies.

  2018cites this paper
• Membranes as modulators of amyloid protein misfolding and target of toxicity.

  2018cites this paper
• Teaching an old scaffold new recognition tricks: oligopyrrolamide antagonists of IAPP aggregation.

  2018cites this paper
• Peptidomimetic-Based Multidomain Targeting Offers Critical Evaluation of Aβ Structure and Toxic Function.

  2018cites this paper
• Discovery and Mechanisms of Small Molecule Amyloid Formation Inhibitors

  2018cites this paper
• Optimizing side chains for crystal growth from water: a case study of aromatic amide foldamers

  2017cites this paper
• Implications of peptide assemblies in amyloid diseases.

  2017cites this paper
• Membrane remodeling by amyloidogenic and non-amyloidogenic proteins studied by EPR.

  2017cites this paper
• Natural product-based amyloid inhibitors.

  2017cites this paper
• Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity

  2017cites this paper
• Foldamer-Mediated Structural Rearrangement Attenuates Aβ Oligomerization and Cytotoxicity.

  2017cites this paper
• α-Helix Mimetics as Modulators of Aβ Self-Assembly.

  2017cites this paper
• Foldamers in Medicinal Chemistry

  2017cites this paper
• Supramolecular Assemblies in Chemical Biology

  2017cites this paper
• Oxazolidinone‐containing pseudopeptides: Supramolecular materials, fibers, crystals, and gels

  2017cites this paper
• Diabetic Risk Factors Promote Islet Amyloid Polypeptide Misfolding by a Common, Membrane-mediated Mechanism

  2016cites this paper
• Mechanism of Inhibition of Human Islet Amyloid Polypeptide-Induced Membrane Damage by a Small Organic Fluorogen

  2016cites this paper
• Molecular Recognition in Biomimetic Receptors

  2016cites this paper
• Membrane Interacting Peptides: A Review.

  2016cites this paper
• Foldamer-mediated manipulation of a pre-amyloid toxin

  2016cites this paper
• Foldamer scaffolds suggest distinct structures are associated with alternative gains-of-function in a preamyloid toxin.

  2016cites this paper
• Multivalent Interactions between an Aromatic Helical Foldamer and a DNA G‐Quadruplex in the Solid State

  2016cites this paper
• Solution Observation of Dimerization and Helix Handedness Induction in a Human Carbonic Anhydrase–Helical Aromatic Amide Foldamer Complex

  2016cites this paper
• β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor

  2016cites this paper
• Islet amyloid-induced cell death and bilayer integrity loss share a molecular origin targetable with oligopyridylamide-based α-helical mimetics.

  2015cites this paper
• Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis

  2015cites this paper
• Proteins at interfaces probed by chiral vibrational sum frequency generation spectroscopy.

  2015cites this paper
• In vitro evaluation of hypoglycemic agents to target human islet amyloid polypeptide: a key protein involved in amyloid deposition and beta-cell loss.

  2015cites this paper
• Charge-Based Inhibitors of Amylin Fibrillization and Toxicity

  2015cites this paper
• Helix mimetics: Recent developments.

  2015cites this paper
• Delineating the Role of Helical Intermediates in Natively Unfolded Polypeptide Amyloid Assembly and Cytotoxicity.

  2015cites this paper
• New Insights from Sum Frequency Generation Vibrational Spectroscopy into the Interactions of Islet Amyloid Polypeptides with Lipid Membranes

  2015cites this paper
• Structure-Based Small Molecule Modulation of a Pre-Amyloid State: Pharmacological Enhancement of IAPP Membrane-Binding and Toxicity.

  2015cites this paper
• Amylin Structure, Aggregation and Pancreatic β Cell Toxicity

  2015influential citation
• Amphiphilic oligoamide α-helix peptidomimetics inhibit islet amyloid polypeptide aggregation

  2015cites this paper
• Defining the mechanism of small molecule inhibition of amyloid fibril formation using ion mobility spectrometry-mass spectrometry

  2015cites this paper
• Rational design of selective small-molecule inhibitors for β-catenin/B-cell lymphoma 9 protein-protein interactions.

  2015cites this paper
• Small molecule screening in context: Lipid‐catalyzed amyloid formation

  2014cites this paper
• Folded small molecule manipulation of islet amyloid polypeptide.

  2014influential citation
• Current view from Alzheimer disease to type 2 diabetes mellitus.

  2014cites this paper
• Fiber-dependent and -independent toxicity of islet amyloid polypeptide.

  2014cites this paper
• Recapitulating the a-helix: nonpeptidic, low-molecular-weight ligands for the modulation of helix-mediated protein-protein

  2013cites this paper
• A foldamer approach to targeting membrane bound helical states of islet amyloid polypeptide.

  2013cites this paper
• Efficient α-helix induction in a linear peptide chain by N-capping with a bridged-tricyclic diproline analogue.

  2013cites this paper
• Synthesis of a tetrasubstituted tetrahydronaphthalene scaffold for α-helix mimicry via a MgBr2-catalyzed Friedel-Crafts epoxide cycloalkylation.

  2013cites this paper
• A common landscape for membrane‐active peptides

  2013cites this paper
• Recapitulating the α-helix: nonpeptidic, low-molecular-weight ligands for the modulation of helix-mediated protein-protein interactions.

  2013cites this paper
• Aromatic amide foldamers: structures, properties, and functions.

  2012cites this paper
• Modeling the Interface between Islet Amyloid Polypeptide and Insulin-Based Aggregation Inhibitors: Correlation to Aggregation Kinetics and Membrane Damage

  2012cites this paper
• Islet amyloid: From fundamental biophysics to mechanisms of cytotoxicity

  2012cites this paper
• Highly neurotoxic monomeric α-helical prion protein

  2012cites this paper
• Concentration‐dependent transitions govern the subcellular localization of islet amyloid polypeptide

  2012cites this paper
• Enaminone-based mimics of extended and hydrophilic α-helices.

  2012cites this paper
• Newly defined toxic α-helical prion protein monomer: implications for other neurodegenerative diseases?

  2012cites this paper
• The role of islet amyloid and CHOP in islet graft dysfunction and failure

  2011cites this paper
• Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: possible link between coffee consumption and diabetes mellitus.

  2011cites this paper
• Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

  2011cites this paper
• A membrane-bound antiparallel dimer of rat islet amyloid polypeptide.

  2011cites this paper
• Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity

  2011cites this paper
• Protein aggregation: p53 succumbs to peer pressure.

  2011cites this paper
• Synthetic alpha-helix mimetics as agonists and antagonists of islet amyloid polypeptide aggregation.

  2010cites this paper
• Hydrogen-bonded synthetic mimics of protein secondary structure as disruptors of protein-protein interactions.

  2010cites this paper
• Solid phase synthesis of aromatic oligoamides: application to helical water-soluble foldamers.

  2010cites this paper
• Emergence and natural selection of drug-resistant prions.

  2010cites this paper
• Disrupting protein-protein interactions with non-peptidic, small molecule alpha-helix mimetics.

  2010cites this paper
• E�cient optical plasmonic tweezer-controlled single-molecule SERS characterization of pH-dependent amylin species in aqueous milieus

  year unknowncites this paper